Alfred Clinical Trials

Alfred Health has more than 700 open trials across 20 clinical disciplines, our clinical trial portfolio is one of the largest in the country.

Clear filter
604 clinical trials found
Clinical trials

TITANIA

A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of Tozorakimab in Participants with Symptomatic Chronic Obstructive Pulmonary Disease (COPD) with a History of COPD Exacerbations. (NCT05158387)

No longer recruiting

POTAT

A Pilot Study of Post Operative Iron Infusion for the Treatment of Anaemia in trauma Patients (ACTRN12624000410550)

Currently recruiting

FMT-CHECKPOINT

A Pilot Study of the Efficacy and Safety of Faecal Microbiota Transplant for the Treatment of Immune Checkpoint Inhibitor Colitis (ACTRN12624000120572)

Currently recruiting

YOGA-AF

A program of yoga in a randomised control study in people with atrial fibrillation (ACTRN12624000264583)

Currently recruiting

POC WATCH HF

A Proof Of Concept study to evaluate the sensitivity and specificity of Wearables and Algorithm Technology for Chronic Heart Disease for improved diagnosis of Heart Failure (ACTRN12623000038695)

Currently recruiting

PORTHOS Study

A Prospective angiOtensin vs. noRadrenaline Trial for Hypotension management to reduce length Of hospital stay in Cardiac Surgery (the PORTHOS study) (ACTRN12623000848606p)

Currently recruiting

FLOODLIGHT MS-MORE ACTIVE

A prospective investigation of the feasibility of smartphone-based self-monitoring to characterize cognitive and neurological impairment in patients with multiple sclerosis (ISRCTN62225263)

Recently completed/closed

PESTO

A Prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality of life at 28 days post treatment. (ACTRN12620001011976)

Currently recruiting

UAE-E

A prospective pilot study of the safety and effectiveness of Uterine Artery Embolisation for the treatment of Endometriosis (ACTRN12622001301752)

Currently recruiting

EPIMINDER

A prospective study to assess the safety of a sub-scalp monitoring device for the recording of brain electrical activity associated with the occurrence of epileptic seizures (ACTRN12619001587190)

Currently recruiting

RENAL BX

A prospective, double-blinded, randomised study comparing 16g automated full-core and side-notch biopsy needles for percutaneous renal biopsies in renal transplant patients (Trial Not Registered)

Currently recruiting

PREVISION

A Prospective, Multicenter, Single Arm, Non-Randomized, Study of BD™ Sirolimus Drug Coated Balloon Catheter for Treatment of Femoropopliteal Arteries (NCT05556681)

Currently recruiting

CSL TAP

A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled, Large Simple Trial Evaluating the Use of BE1116 (4-Factor Prothrombin Complex Concentrate [Kcentra® / Beriplex® ]) to Improve Survival in Patients with Traumatic Injury and Acute Major Bleeding (NCT05568888)

No longer recruiting

PiVET-ED

A prospective, randomized, single-blinded, sham controlled study of Pelvic Vein Embolization (PVE) for treatment of erectile dysfunction (ED) (ACTRN12620001023943)

Currently recruiting

ENCOMPASS

A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During Transcatheter Aortic Valve Replacement (NCT05893082)

Currently recruiting

REBUILD-SM

A Randomised Clinical Trial of a digital Self-Management package for people with Interstitial Lung Disease (ACTRN12623001133628)

Currently recruiting

ECMO-REHAB

A Randomised Controlled Trial of Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation (ECMO-Rehab) (NCT05003609)

No longer recruiting

SOCRATES

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (ACTRN12621001444875p)

Currently recruiting

IVIG Therapy in Lung Tx

A Randomised Double-blind Placebo-controlled Pilot Study of Intravenous Immunoglobulin Replacement Therapy in Lung Transplantation (ACTRN12618001394235)

No longer recruiting

SiroSkin

A randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients (NCT05860881)

Currently recruiting
12 13 14 15 16